Evolution of the Relationship Between Central and Peripheral Arterial Wave Velocities as a Function of Age

NCT ID: NCT06742775

Last Updated: 2024-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-02-28

Study Completion Date

2027-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acquisition of synchronized cardiovascular signals from non-invasive measurements (ECG, photoplethysmography pulse sensors, inductance plethysmography) in healthy volunteers aged from 18 to 75, during spontaneous ventilation with apneas (20 seconds) for a total acquisition time of 30 minutes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aging Diagnostic Techniques, Cardiovascular

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

photoplethysmography electrocardiography inductive plethysmography Pulse Wave Velocity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Under 30

Healthy volunteers younger than 30 years

physiological signal acquisitions

Intervention Type OTHER

Subjects will be fitted with non-intrusive devices. In a semi-recumbent position, they will be asked to perform

* 10 minutes of resting breathing
* 10 cycles consisting of a 20-second apnea, to be performed at the end of inspiration, and 1 minute 40 of breathing (100 seconds).

This single participation session will last a total of one hour for the volunteer (equipment, recording, de-equipping), including 30 minutes of acquisition.

Between 30 and 50

Healthy volunteers between 30 and 50 years

physiological signal acquisitions

Intervention Type OTHER

Subjects will be fitted with non-intrusive devices. In a semi-recumbent position, they will be asked to perform

* 10 minutes of resting breathing
* 10 cycles consisting of a 20-second apnea, to be performed at the end of inspiration, and 1 minute 40 of breathing (100 seconds).

This single participation session will last a total of one hour for the volunteer (equipment, recording, de-equipping), including 30 minutes of acquisition.

More than 50

Healthy volunteers older than 50 years

physiological signal acquisitions

Intervention Type OTHER

Subjects will be fitted with non-intrusive devices. In a semi-recumbent position, they will be asked to perform

* 10 minutes of resting breathing
* 10 cycles consisting of a 20-second apnea, to be performed at the end of inspiration, and 1 minute 40 of breathing (100 seconds).

This single participation session will last a total of one hour for the volunteer (equipment, recording, de-equipping), including 30 minutes of acquisition.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

physiological signal acquisitions

Subjects will be fitted with non-intrusive devices. In a semi-recumbent position, they will be asked to perform

* 10 minutes of resting breathing
* 10 cycles consisting of a 20-second apnea, to be performed at the end of inspiration, and 1 minute 40 of breathing (100 seconds).

This single participation session will last a total of one hour for the volunteer (equipment, recording, de-equipping), including 30 minutes of acquisition.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women between 18 and 75 years of age
* No acute cardiovascular pathologies less than 2 years old,
* No chronic cardiovascular pathologies.
* Stature compatible with the use of the plethysmography T-shirt.
* Person affiliated to a social security scheme or beneficiary of such a scheme
* Signed informed consent form

Exclusion Criteria

* Persons covered by articles L1121-5 to L1121-8 of the CSP (corresponding to all protected persons: pregnant women, parturients, nursing mothers, persons deprived of their liberty by judicial or administrative decision, persons under psychiatric care under articles L. 3212-1 and L. 3213-1 who are not covered by the provisions of article L. 1121-8, persons admitted to a health or social establishment for purposes other than research, minors, persons under legal protection or unable to express their consent).
* Personnel with a hierarchical link to the principal investigator
* Subjects excluded from another study,
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Grenoble Alps

OTHER

Sponsor Role collaborator

University Hospital, Grenoble

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stéphane TANGUY

Role: PRINCIPAL_INVESTIGATOR

University Grenoble Alpes

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Laboratoire TIMC

Grenoble, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Stéphane TANGUY

Role: CONTACT

Phone: +33476637117

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Stéphane TANGUY

Role: primary

Julie Fontecave

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Diaz A, Galli C, Tringler M, Ramirez A, Cabrera Fischer EI. Reference values of pulse wave velocity in healthy people from an urban and rural argentinean population. Int J Hypertens. 2014;2014:653239. doi: 10.1155/2014/653239. Epub 2014 Aug 24.

Reference Type BACKGROUND
PMID: 25215227 (View on PubMed)

Fontecave-Jallon J, Tanguy S. Inductive Plethysmography for aortic Pulse Wave Velocity. Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:2711-2714. doi: 10.1109/EMBC44109.2020.9175329.

Reference Type BACKGROUND
PMID: 33018566 (View on PubMed)

Fortier C, Agharazii M. Arterial Stiffness Gradient. Pulse (Basel). 2016 Apr;3(3-4):159-66. doi: 10.1159/000438852. Epub 2015 Sep 2.

Reference Type BACKGROUND
PMID: 27195235 (View on PubMed)

Fortier C, Sidibe A, Desjardins MP, Marquis K, De Serres SA, Mac-Way F, Agharazii M. Aortic-Brachial Pulse Wave Velocity Ratio: A Blood Pressure-Independent Index of Vascular Aging. Hypertension. 2017 Jan;69(1):96-101. doi: 10.1161/HYPERTENSIONAHA.116.08409. Epub 2016 Nov 7.

Reference Type BACKGROUND
PMID: 27821616 (View on PubMed)

Heffernan KS, Stoner L, London AS, Augustine JA, Lefferts WK. Estimated pulse wave velocity as a measure of vascular aging. PLoS One. 2023 Jan 26;18(1):e0280896. doi: 10.1371/journal.pone.0280896. eCollection 2023.

Reference Type BACKGROUND
PMID: 36701358 (View on PubMed)

Yu S, McEniery CM. Central Versus Peripheral Artery Stiffening and Cardiovascular Risk. Arterioscler Thromb Vasc Biol. 2020 May;40(5):1028-1033. doi: 10.1161/ATVBAHA.120.313128. Epub 2020 Mar 19.

Reference Type BACKGROUND
PMID: 32188277 (View on PubMed)

Weber T, Wassertheurer S, Hametner B, Parragh S, Eber B. Noninvasive methods to assess pulse wave velocity: comparison with the invasive gold standard and relationship with organ damage. J Hypertens. 2015 May;33(5):1023-31. doi: 10.1097/HJH.0000000000000518.

Reference Type BACKGROUND
PMID: 25668350 (View on PubMed)

Wang J, Jing C, Hu X, Cui J, Tang Q, Tu L, Zhao S, Huang J, Guo D, Li Y, Xu J. Assessment of aortic to peripheral vascular stiffness and gradient by segmented upper limb PWV in healthy and hypertensive individuals. Sci Rep. 2023 Nov 13;13(1):19859. doi: 10.1038/s41598-023-46932-0.

Reference Type BACKGROUND
PMID: 37963909 (View on PubMed)

Townsend RR, Wilkinson IB, Schiffrin EL, Avolio AP, Chirinos JA, Cockcroft JR, Heffernan KS, Lakatta EG, McEniery CM, Mitchell GF, Najjar SS, Nichols WW, Urbina EM, Weber T; American Heart Association Council on Hypertension. Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association. Hypertension. 2015 Sep;66(3):698-722. doi: 10.1161/HYP.0000000000000033. Epub 2015 Jul 9. No abstract available.

Reference Type BACKGROUND
PMID: 26160955 (View on PubMed)

Sztrymf B, Jacobs F, Chemla D, Richard C, Millasseau SC. Validation of the new Complior sensor to record pressure signals non-invasively. J Clin Monit Comput. 2013 Dec;27(6):613-9. doi: 10.1007/s10877-013-9477-y. Epub 2013 May 17.

Reference Type BACKGROUND
PMID: 23681924 (View on PubMed)

Salvi P, Valbusa F, Kearney-Schwartz A, Labat C, Grillo A, Parati G, Benetos A. Non-Invasive Assessment of Arterial Stiffness: Pulse Wave Velocity, Pulse Wave Analysis and Carotid Cross-Sectional Distensibility: Comparison between Methods. J Clin Med. 2022 Apr 15;11(8):2225. doi: 10.3390/jcm11082225.

Reference Type BACKGROUND
PMID: 35456316 (View on PubMed)

Salvi P, Lio G, Labat C, Ricci E, Pannier B, Benetos A. Validation of a new non-invasive portable tonometer for determining arterial pressure wave and pulse wave velocity: the PulsePen device. J Hypertens. 2004 Dec;22(12):2285-93. doi: 10.1097/00004872-200412000-00010.

Reference Type BACKGROUND
PMID: 15614022 (View on PubMed)

Obeid H, Khettab H, Marais L, Hallab M, Laurent S, Boutouyrie P. Evaluation of arterial stiffness by finger-toe pulse wave velocity: optimization of signal processing and clinical validation. J Hypertens. 2017 Aug;35(8):1618-1625. doi: 10.1097/HJH.0000000000001371.

Reference Type BACKGROUND
PMID: 28379892 (View on PubMed)

Karimpour P, May JM, Kyriacou PA. Photoplethysmography for the Assessment of Arterial Stiffness. Sensors (Basel). 2023 Dec 17;23(24):9882. doi: 10.3390/s23249882.

Reference Type BACKGROUND
PMID: 38139728 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

38RC24.0299

Identifier Type: -

Identifier Source: org_study_id